[go: up one dir, main page]

AR052744A1 - Composiciones que comprenden componentes probioticos y edulcorantes - Google Patents

Composiciones que comprenden componentes probioticos y edulcorantes

Info

Publication number
AR052744A1
AR052744A1 ARP060101416A ARP060101416A AR052744A1 AR 052744 A1 AR052744 A1 AR 052744A1 AR P060101416 A ARP060101416 A AR P060101416A AR P060101416 A ARP060101416 A AR P060101416A AR 052744 A1 AR052744 A1 AR 052744A1
Authority
AR
Argentina
Prior art keywords
composition
edulcorant
compositions
components
probiotic
Prior art date
Application number
ARP060101416A
Other languages
English (en)
Inventor
Marko Stojanovic
Original Assignee
Iams Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iams Company filed Critical Iams Company
Publication of AR052744A1 publication Critical patent/AR052744A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composicion que comprende (a) un componente probiotico; y (b) un componente edulcorante; en donde la composicion prácticamente carece de una base de goma de mascar. Dicha composicion en donde el componente probiotico comprende bacterias del grupo formado por Bacillus, Bacteroides, Bifidobacterium, Enterococcus, Lactobacillus, y Leuconostoc, y combinaciones de éstos, y en donde el edulcorante se selecciona del grupo gormado por monosacáridos, disacáridos, y mezclas de éstos. Dicha composicion que comprende de 0,001% a 10% de la bacteria y 50% a 99% de sorbitol, en peso de la composicion. Uso de dicha composicion para mejorar la salud de un mamífero.
ARP060101416A 2005-04-11 2006-04-10 Composiciones que comprenden componentes probioticos y edulcorantes AR052744A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67012505P 2005-04-11 2005-04-11
US11/384,050 US20100233312A9 (en) 2005-04-11 2006-03-17 Compositions comprising probiotic and sweetener components

Publications (1)

Publication Number Publication Date
AR052744A1 true AR052744A1 (es) 2007-03-28

Family

ID=36992608

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060101416A AR052744A1 (es) 2005-04-11 2006-04-10 Composiciones que comprenden componentes probioticos y edulcorantes

Country Status (8)

Country Link
US (1) US20100233312A9 (es)
EP (1) EP1868624A2 (es)
JP (1) JP2008535520A (es)
AR (1) AR052744A1 (es)
AU (1) AU2006235038B2 (es)
BR (1) BRPI0609456A2 (es)
CA (2) CA2604835C (es)
WO (1) WO2006110406A2 (es)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8192733B2 (en) * 2003-08-29 2012-06-05 Cobb & Associates Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
EP1885383B1 (en) 2005-05-31 2016-09-21 IAMS Europe B.V. Feline probiotic bifidobacteria
DK1880001T3 (da) 2005-05-31 2011-09-12 Iams Company Feline probiotiske lactobacilli
MX2008011958A (es) * 2006-03-29 2008-10-01 Nestec Sa Suplementos dieteticos que contienen probioticos.
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
ES2551719T3 (es) 2007-02-01 2015-11-23 Iams Europe B.V. Procedimiento para disminuir la inflamación y el estrés en un mamífero usando antimetabolitos de glucosa, aguacate o extractos de aguacate
FR2915388B1 (fr) * 2007-04-27 2010-12-24 Oreal Film hydrosoluble cosmetique
PL2173196T3 (pl) * 2007-07-06 2011-06-30 Nutricia Nv Zastosowanie probiotyków i włókien w biegunce
CN101903032A (zh) * 2007-10-26 2010-12-01 布伦达·E.·穆尔 益生菌组合物及用来引起和维持体重减轻的方法
US8071150B2 (en) * 2007-12-21 2011-12-06 Frito-Lay North America, Inc. Processing technique to thaw partially frozen fruits and vegetables and incorporating solids
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
WO2010086705A2 (en) * 2009-01-27 2010-08-05 Probiotical S.P.A. Chocolate flavoured probiotic supplement
IT1393415B1 (it) * 2009-01-27 2012-04-20 Probiotical Spa Integratore probiotico al gusto di cioccolato
US8691303B2 (en) * 2009-07-31 2014-04-08 The Iams Company Dusted animal food
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US9210945B2 (en) * 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
US9173423B2 (en) * 2009-07-31 2015-11-03 The Iams Company Animal food kibble with electrostatically adhered dusting
US20110027420A1 (en) * 2009-07-31 2011-02-03 Haile Mehansho Moisture migration reduction layer for a food product
US20110027417A1 (en) 2009-07-31 2011-02-03 Patrick Joseph Corrigan Process for Dusting Animal Food
EP2295535A1 (en) * 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
US20110081320A1 (en) * 2009-10-06 2011-04-07 Nubiome, Inc. Treatment/Cure of Autoimmune Disease
US20110123677A1 (en) * 2009-11-25 2011-05-26 Pepsico, Inc. High acid beverage products and methods to extend probiotic stability
WO2012048152A2 (en) * 2010-10-07 2012-04-12 Mazmanian Sarkis K Probiotic therapies for autism
FR2968004B1 (fr) * 2010-11-29 2013-06-28 Sojasun Technologies Films naturels biodegradables a base de co-produits issus de processus industriels de traitement de graines.
EP2654453B1 (en) 2010-12-23 2016-06-01 Hill's Pet Nutrition, Inc. Pet food compositions and methods for weight loss and maintenance
CA2822337C (en) 2010-12-23 2016-10-04 Hill's Pet Nutrition, Inc. Pet food compositions and methods for treating arthritis and inflammation associated with arthritis
WO2012097018A1 (en) 2011-01-14 2012-07-19 The Iams Company Compositions and methods relating to carotenoids
RU2631597C2 (ru) 2011-07-15 2017-09-25 Нусерт Сайенсиз, Инк. Композиции и способы модулирования метаболических путей
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
JP2014534819A (ja) * 2011-11-14 2014-12-25 ザ・アイムス・カンパニーＴｈｅ Ｉａｍｓ Ｃｏｍｐａｎｙ 嗜好性ペットフード及びペットフードの嗜好性を改善する方法
AU2011383737B2 (en) 2011-12-19 2015-02-05 Hill's Pet Nutrition, Inc. Highly digestible pet food for improving stool quality
US9585925B1 (en) * 2012-05-04 2017-03-07 Vetnique Labs LLC Pet food supplement
EP2890808A4 (en) 2012-08-29 2016-09-28 California Inst Of Techn DIAGNOSIS AND TREATMENT OF AUTISTICAL DISEASES
CN108295058A (zh) 2012-11-13 2018-07-20 纽斯尔特科学公司 用于增强能量代谢的组合物和方法
CA2903752A1 (en) * 2013-03-15 2014-09-25 Nusirt Sciences, Inc. Treatment of pets with sirtuin activators
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
US10124025B2 (en) 2014-10-30 2018-11-13 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
KR20170086492A (ko) 2014-10-30 2017-07-26 캘리포니아 인스티튜트 오브 테크놀로지 신경발달 장애에서의 행동을 개선시키기 위한 박테리아를 포함하는 조성물 및 방법
KR20220151045A (ko) 2014-12-23 2022-11-11 4디 파마 리서치 리미티드 면역 조정
EP3193901B1 (en) 2014-12-23 2018-04-04 4D Pharma Research Limited Pirin polypeptide and immune modulation
EP3258792A1 (en) 2015-02-16 2017-12-27 Mars, Incorporated Interlocking kibble
AU2016255437B2 (en) 2015-04-28 2020-10-08 Mars, Incorporated Process of preparing a sterilized wet pet food product
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
EP3240554B1 (en) 2015-06-15 2019-07-31 4D Pharma Research Limited Blautia stercosis and wexlerae for use in treating inflammatory and autoimmune diseases
ES2910946T3 (es) 2015-06-15 2022-05-17 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
MX2017016529A (es) 2015-06-15 2018-03-12 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas.
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
ME03003B (me) 2015-11-20 2018-10-20 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
RU2706953C1 (ru) * 2015-12-30 2019-11-21 Хиллс Пет Нутришн, Инк. Композиции корма для домашних животных с контролируемым высвобождением для доставки источника полифенола
TW201733601A (zh) 2016-03-04 2017-10-01 ４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
EP3465212A4 (en) 2016-05-23 2020-01-08 California Institute of Technology REGULAR FLORAL REGULATION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
USD805728S1 (en) 2016-09-06 2017-12-26 Mars, Incorporated Food product
USD806351S1 (en) 2016-09-06 2018-01-02 Mars, Incorporated Food product
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
GB201701417D0 (en) 2017-01-27 2017-03-15 Mars Inc Pet food
WO2018213204A1 (en) 2017-05-15 2018-11-22 Axial Biotherapeutics, Inc. Inhibitors of microbially induced amyloid
JP2020520911A (ja) 2017-05-22 2020-07-16 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物
WO2018215782A1 (en) 2017-05-24 2018-11-29 4D Pharma Research Limited Compositions comprising bacterial strain
HUE052319T2 (hu) 2017-06-14 2021-04-28 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
IL283973B (en) 2017-06-14 2022-08-01 4D Pharma Res Ltd Compositions comprising bacterial strains
TWI812624B (zh) 2017-06-14 2023-08-21 南韓商希杰生物科技股份有限公司 包含細菌品系之組成物
US20230256002A1 (en) * 2022-02-11 2023-08-17 Keith Allen Garleb Hard lozenge made with dietary fiber

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4055676A (en) * 1975-05-20 1977-10-25 The Quaker Oats Company Replacement of sugar in a sugar-containing food and process
US4565702A (en) * 1984-06-04 1986-01-21 Warner-Lambert Company Dietary fiber food products and method of manufacture
ATE123387T1 (de) * 1990-11-26 1995-06-15 Nestle Sa Verfahren und vorrichtung zum herstellen von nahrungsmitteln durch koch-koextrusion.
JPH08126473A (ja) * 1994-09-08 1996-05-21 Fuji Oil Co Ltd 油性組成物およびその製法並びにそれを用いた油性被覆菓子
PT862863E (pt) * 1997-01-09 2002-04-29 Nestle Sa Produto cerealifero contendo probioticos
US6133323A (en) * 1997-04-09 2000-10-17 The Iams Company Process for enhancing immune response in animals using β-carotene as a dietary supplement
ES2173372T3 (es) * 1997-12-19 2002-10-16 Merck Patent Gmbh Comprimidos multicapa que contienen microorganismos probioticos, como por ejemplo latobacilos o bifidobacterias.
US6100388A (en) * 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
DK1074250T3 (da) * 1998-04-30 2004-07-19 Morinaga Milk Industry Co Ltd Sukkerovertrukne tabletter
US20040161422A1 (en) * 1999-04-30 2004-08-19 Natarajan Ranganathan Nutritional compositions comprising probiotics
AU777263B2 (en) * 1999-05-12 2004-10-07 Cp Kelco Aps Food composition with high solids content, a method for its preparation as well as the use of carrageenans for gelling a food composition
TR200103413T2 (tr) * 1999-05-27 2002-04-22 The Iams Company Bir antioksidan bileşimi kullanarak ev hayvanlarında immün cevabı arttırmak için yöntem ve ürün
DE19937361A1 (de) * 1999-08-12 2001-02-22 Merck Patent Gmbh Orale Darreichungsform
JP2001321094A (ja) * 2000-05-12 2001-11-20 Kenji Tokunaga 乳酸菌を含むローヤルゼリー錠剤の製造方法
ES2262667T3 (es) * 2000-05-25 2006-12-01 Societe Des Produits Nestle S.A. Probioticos nuevos para aplicaciones en alimento para animales de compañia.
GB0027761D0 (en) * 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
ATE423475T1 (de) * 2001-11-12 2009-03-15 Mars Inc Nahrungsmittel für katzen und hunde
US20050008735A1 (en) * 2002-02-11 2005-01-13 Pearce Tony M. Chocolate polymer snacks
EP1344458A1 (en) * 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
ITBO20020564A1 (it) * 2002-09-06 2004-03-07 Alfa Wassermann Spa Bifidobatteri e preparazioni che li contengono.
US8168170B2 (en) * 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
ITMI20022343A1 (it) * 2002-11-05 2004-05-06 Biofarm Srl Pellicola a rapida dissoluzione in acqua, contenente sistanze cosmetiche, aromatiche, farmaceutiche o alimentari.
US20040202698A1 (en) * 2003-04-02 2004-10-14 The Procter & Gamble Company Drug delivery systems comprising an encapsulated active ingredient
US20050136095A1 (en) * 2003-12-22 2005-06-23 Brian Levy Drug delivery device with suture ring
US20080102163A1 (en) * 2004-07-01 2008-05-01 General Mills, Inc. Cultures Encapsulated With Chocolate Food Products Coated With Chocolate And Method Of Preparation
US20060228448A1 (en) * 2005-04-11 2006-10-12 The Iams Company Pet food compositions comprising two components

Also Published As

Publication number Publication date
AU2006235038A1 (en) 2006-10-19
CA2604835C (en) 2014-12-30
US20100233312A9 (en) 2010-09-16
WO2006110406A3 (en) 2007-07-12
WO2006110406A2 (en) 2006-10-19
EP1868624A2 (en) 2007-12-26
CA2604835A1 (en) 2006-10-19
AU2006235038B2 (en) 2011-05-19
CA2875889A1 (en) 2006-10-19
US20070218164A1 (en) 2007-09-20
CA2875889C (en) 2018-04-24
BRPI0609456A2 (pt) 2010-04-06
JP2008535520A (ja) 2008-09-04

Similar Documents

Publication Publication Date Title
AR052744A1 (es) Composiciones que comprenden componentes probioticos y edulcorantes
AR066878A1 (es) Composiciones cosmeticas con resistencia a la transferencia mejorada
CR20150097A (es) Composición inmunogénica
CL2013001367A1 (es) Conjunto de composiciones nutricionales para lactantes y niños pequeños que comprende una primera composicion para lactantes de 0 a 6 meses, una segunda composicion para lactantes de 6 meses y 1 año, y una tercera composicion para niños pequeños de 1 a 2 años, donde la primera y segunda composicion comprenden probioticos difiriendo entre si por la cantidad y/o naturaleza de los mismos; y su uso para prevenir y/o tratar diarrea entre otros desordenes.
ECSP12011935A (es) Triazolopiridinas
ATE474585T1 (de) Probiotische enterokokken für eine verbesserte immunität
HN2005000795A (es) Pirimidinas como antagonistas del receptor de prostaglandina d2
RS51185B (sr) Kompozicije za vaginalnu primenu
CL2012000869A1 (es) Composicion que comprende cepa seleccionada de lactobacillus plantarum cect 7527, o cepas mutantes de la misma; uso de una composicion para prevenir y/o tratar transtornos cardiovasculares.
BRPI0921002A8 (pt) Composições para tratamento bucal compreendendo sílica fundida e seu uso
AR058648A1 (es) Sistema abrasivo para composiciones de cuidado oral
CL2011001940A1 (es) Uso de lactobacillus rhamnosus cncm i-4007 y una formulacion de prebioticos que comprende oligofructosa e inulina para apoyar la perdida de peso y/o mantenimiento del peso en humanos y/o animales.
TW200716584A (en) Dihydrobenzofuran derivatives and uses thereof
CL2008003016A1 (es) Composicion para tratamiento de lavanderia que comprende una base de tratamiento de lavanderia y desde 0,01 a 10% en peso de particulas de film laminar concavas coloreadas.
ATE528012T1 (de) Uronsäure und probiotika
CL2008001157A1 (es) Compuestos derivados de quinolina-carboxamida, antagonistas de p2y12; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; composicion de una combinacion de dichos compuestos; y uso del compuesto en el tratamiento de trastornos cardiovasculares, tromboembolismo, infarto agudo al miocardio.
CO6290630A2 (es) Composición oral que contiene amino ácidos y particulas pequeñas
ECSP11010975A (es) Método de uso de una cepa de bacillus subtilis para mejorar la salud de animales
SG10201901259RA (en) Prebiotic formulations and methods of use
AR054347A1 (es) Combinaciones terapeuticas para el tratamiento o la prevencion de la depresion
AR079606A1 (es) Ligante hidraulico para materiales de construccion
ATE537707T1 (de) Lactobacillus paracasei und gewichtskontrolle
MX2012002402A (es) Bifidobacterium longum y trastornos gastrointestinales funcionales.
MX2009012694A (es) Composicones y metodos utiles para modular la inmunidad, mejorar la eficacia de vacunas, disminuir la morbilidad asociada con infecciones cronicas por fhv-1, y prevenir o tratar la conjuntivitis.
MY163703A (en) Cement compositions comprising particulate carboxylated elastomers and associated methods

Legal Events

Date Code Title Description
FG Grant, registration